ABINGDON, England, October 6, 2017 /PRNewswire/ --
OBN (UK) Ltd, the membership organisationthat supports the life sciences industry, are delighted to announce the winners of the prestigious OBN Awards 2017 that were presented last night in front of a sold-out audience of over 250 life science industry leaders at the Town Hall in Oxford.
John Harris, CEO of OBN , said: "We received an outstanding number of entries this year; up a staggering 120% on last year, so competition was really tough. All of our winners and nominees this year are truly innovative and set a great example to the rest of the industry. We would like to thank all of our sponsors and supporters for helping make the awards a success, which acts as a reflection of how buoyant and supportive the industry is today."
The winners are:
Award one: Best Start-up Biotech, Kindly sponsored by EY
Winner - Microbiotica
For their work in transforming personalised medicine with microbiome science
Award two: Best Emerging Biotech, Kindly sponsored by Covance
Winner - Exscientia
For applying AI and big data processing to accelerate drug discovery and development
Award three: Best Established Biotech, Kindly sponsored by Penningtons Manches
Winner - PsiOxus Therapeutics
For realising the potential of immuno-oncolytic viruses for treatment of solid tumours
Award four: Best Contract Research Organisation; kindly sponsored by Ipsen Bioinnovation
Winner - Sygnature Discovery
For their work in supporting the acceleration of the discovery of new medicines from the laboratory into development to treat patients with a range of debilitating and fatal diseases
Award five: Highest Impact Investor, Kindly sponsored by MEPC Milton Park
Winner - Innovate UK
For the pump priming, support and leverage they have provided to companies in the life sciences industry over the past year
Award six: Best UK Life Sciences Incubator, Kindly sponsored by Precision Oncology
Winner - BioHub at Alderley Park
For their outstanding work as the epicentre for life science technology in the North West
Award seven: Best Start-up Medtech, Kindly sponsored by Premier Research
Winner - Oxford Endovascular
For creating novel 'origami-like' stents with improved performance and lower patient risk for treatment of intracranial aneurysms
Award eight: Best Emerging Medtech, Kindly sponsored by Team Consulting
Winner - Perspectum Diagnostics
For commercialising LiverMultiScan, a non-invasive medical imaging software tool which enhances the effectiveness of the diagnostic pathway for patients with chronic liver disease
Award nine: Best Synthetic Biology Company, Kindly sponsored and judged exclusively by SynbiCITE
Winner - Synpromics
For enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelligent data driven design
Award ten: Best Implementation of Digital Healthcare, Kindly sponsored by James Cowper Kreston
Winner - Adherium
For providing smart personal medication monitoring systems to help patients manage their chronic respiratory conditions
Award eleven: Best Public-Private Collaboration, Kindly sponsored by Oxford AHSN
Winner - The University of Oxford, Oxford University Innovation, Oxford University Hospitals NHS Foundation Trust and Drayson Technologies
For signing a strategic research agreement to evaluate, develop and commercialise digital health applications including GDm-Health for the management of gestational diabetes.
Award twelve: Outstanding Achievement Award, Kindly sponsored by Lloyds Bank & N+1 Singer
Winner - BioHub at Alderley Park
For embodying the criteria of this award by overcoming challenges, thinking more innovatively and simply working hard to succeed.
Award thirteen: Special Recognition Award
Winner - Julian Golec
For his long service to the life sciences industry
About the OBN Annual Awards - www.obn-awards.com
The OBN Awards, now in its 9th year, celebrate innovation and achievement across the UK life sciences Industry. We are proud that the awards remain independent with categories that cover Biotech, Medtech, Synthetic Biology and Digital Health and recognise achievements from emerging to late stage R&D companies to large pharma and life sciences investors.
OBN Awards 2017 Independent Judging Panel
Dara Henry - VP of Operations & Business Development, Achilles Therapeutics
Bryan Morton - Executive Chair - EUSA Pharma & VH2
Sue Charles - Managing Partner - Instinctif Partners
Ewa Truchanowicz - Business Engagement Manager - The BioHub Birmingham
Alan O'Connell - Partner - Seroba Life Sciences
John Chaddock - Vice President - Neurology, Site Head - Ipsen
Bill Fleming - CFO - Oxitec
Caroline Barelle - CFO - Elasmogen
Anton Hutter - Partner & Patent Attorney - Venner Shipley
Carolyn Porter - Deputy Head of Technology Transfer - OUI
About OBN - www.obn.org.uk
OBN is the Membership organisation supporting and bringing together the UK's emerging life sciences companies, corporate partners and investors. Our 400 member companies are located across the Golden Triangle and beyond to, Birmingham, Nottingham, Manchester, the North East and Scotland, all benefit from our networking, partnering, purchasing, advising and advocacy activities.
Further information about OBN's tailored networking and partnering events, purchasing consortium, advice, consultancy services and advocacy activities is available on OBN's website www.obn.org.uk .
Event enquiries and picture requests:
Jane O'Driscoll, Head of Events, OBN - Email: firstname.lastname@example.org
Sylvie Berrebi, Director, Citigate Dewe Rogerson - Email: Sylvie.email@example.com
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All